Round Rock Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-741
Closed -$431K – 193
2024
Q1
$431K Hold
741
– – 0.1% 127
2023
Q4
$393K Buy
741
+1
+0.1% +$484 0.1% 129
2023
Q3
$375K Sell
740
-3
-0.4% -$1.6K 0.14% 98
2023
Q2
$388K Buy
743
+1
+0.1% +$540 0.14% 100
2023
Q1
$428K Hold
742
– – 0.16% 94
2022
Q4
$409K Hold
742
– – 0.17% 95
2022
Q3
$376K Hold
742
– – 0.17% 94
2022
Q2
$403K Sell
742
-82
-10% -$45.1K 0.18% 86
2022
Q1
$487K Buy
+824
New +$473K 0.2% 82

Other funds holding TMO

Round Rock Advisors's TMO Position: Q2 2024 in Review

Round Rock Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 741 shares — an estimated $431K sold.

Round Rock Advisors first reported a position in TMO in Q1 2022 and held it in 9 quarters. The position peaked at $487K in Q1 2022. 2,548 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Round Rock Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Round Rock Advisors sold 741 Thermo Fisher Scientific shares in Q2 2024, an estimated $431K.
  • Round Rock Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 9 quarters.
  • Round Rock Advisors's Thermo Fisher Scientific position peaked at $487K in Q1 2022.
  • 2,548 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Round Rock Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.